Last reviewed · How we verify
Vehicle Opthalmic Solution
Vehicle Ophthalmic Solution is a non-medicated solution used to flush out the eye.
Vehicle Ophthalmic Solution is a non-medicated solution used to flush out the eye. Used for Treatment of dry eye disease.
At a glance
| Generic name | Vehicle Opthalmic Solution |
|---|---|
| Sponsor | Aldeyra Therapeutics, Inc. |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
It does not contain any active pharmaceutical ingredients and is used to remove debris, bacteria, or other foreign particles from the eye. This solution is often used after eye surgery or to treat eye irritation.
Approved indications
- Treatment of dry eye disease
Common side effects
- Eye irritation
Key clinical trials
- Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia (PHASE3)
- Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 (PHASE3)
- RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD (PHASE2)
- The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease (PHASE2, PHASE3)
- A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease (PHASE2)
- Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia (PHASE3)
- Phase 3 Safety Study for the Treatment of Presbyopia Subjects (PHASE3)
- Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle Opthalmic Solution CI brief — competitive landscape report
- Vehicle Opthalmic Solution updates RSS · CI watch RSS
- Aldeyra Therapeutics, Inc. portfolio CI